Andrew D. Dickinson - 10 Dec 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Financial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Issuer symbol
GILD
Transactions as of
10 Dec 2025
Net transactions value
-$211,738
Form type
4
Filing time
11 Dec 2025, 20:40:00 UTC
Previous filing
18 Nov 2025
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dickinson Andrew D Chief Financial Officer GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson 11 Dec 2025 0001310204

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3,693 +2.4% 158,248 10 Dec 2025 Direct F1
transaction GILD Common Stock Tax liability $211,738 -1,745 -1.1% $121.34 156,503 10 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3,693 -12% 27,526 10 Dec 2025 Common Stock 3,693 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.